Knoll Capital Management, LLC
CIK: 1325083
Decreased
0
Holdings (37)
Q2 2026 13F, quarter ended Jun 30, 2026, filed Aug 14, 2026
- BHVN1
Biohaven Pharmactl Hldg Co
$35.01M
2.35M sh16.33%+1.0% - MGTX
MeiraGTX Holdings
$16.89M
1.25M sh7.88%+0.0% - PHYS
Sprott physical gold Trust
$11.68M
387,055 sh5.45%+0.0% - ALDX
Aldeyra Therapeutics Inc
$11.66M
5.48M sh5.44%+0.0% - OCUL
Ocular Therapeutix Inc.
$11.3M
1.15M sh5.27%+91.6% - RGLD
Royal Gold Inc.
$10.53M
52,750 sh4.91%+0.0% - ENTX
Entera Bio Ltd
$10.41M
5.88M sh4.86%+0.0% - NUVB
Nuvation Bio Inc
$9.08M
1.60M sh4.24%+6.7% - AEM
Agnico Eagle Mines Ltd
$8.18M
52,750 sh3.82%+0.0% - SA
SEABRIDGE GOLD INC
$8.16M
317,003 sh3.81%+0.0% - KGC
Kinross Gold Corp
$7.56M
320,000 sh3.53%+0.0% - OR
OR Royalties
$7.12M
225,000 sh3.32%+0.0% - SSRM
SSR Mining In
$6.93M
245,000 sh3.23%+0.0% - FNV
Franco Nev Corp
$6.67M
32,000 sh3.11%+0.0% - BAH
Booz Allen Hamilton HLDG COR
$5.69M
13,000 sh2.66%+0.0% - CGAU
Centerra Gold Inc
$5.69M
359,000 sh2.66%+0.0% - ELTX
Elicio Therapeutics Inc
$4.74M
1.21M sh2.21%+92.1% - ABVX
Abivax SA Spons
$4.66M
35,000 sh2.18%New - PAAS
Pan American Silver
$4.48M
100,035 sh2.09%+0.0% - PSLV
Sprott Physical silver Trust
$4.19M
222,160 sh1.96%+0.0% - TFPM
Triple Flag Precious Metals
$3.45M
115,000 sh1.61%+0.0% - ABEO
Abeona Therapeutics
$3M
485,515 sh1.40%+0.0% - GROY
Gold RTY Corp
$2.76M
1.00M sh1.29%+0.0% - NEWP
New Pac Metals Corp
$1.95M
485,000 sh0.91%+0.0% - ITA
iSHares US Aerospace & Defense
$1.85M
7,650 sh0.87%+0.0% - PM
Philip Morris Intl. Inc
$1.81M
10,000 sh0.84%+0.0% - CDE
Coeur Mining Inc
$1.57M
96,132 sh0.73%+0.0% - AGI
Alamos Gold Inc
$1.52M
50,000 sh0.71%+0.0% - WPM
Wheaton Precious Metals Corp
$1.4M
12,500 sh0.66%+0.0% - NOC
Northrop Grumman Corp
$1.1M
2,165 sh0.51%+0.0% - ELE
Elemental RTY Corp
$873K
50,000 sh0.41%+0.0% - VMET
Versamet Royalties Corp
$821K
66,621 sh0.38%+0.0% - DC
Dakota Gold Corp
$524K
122,921 sh0.24%+0.0% - AMRZ
Amrize LTD
$489K
9,175 sh0.23%+0.0% - ALT
Altimmune Inc
$486K
160,000 sh0.23%+0.0% - PHAR
Pharming Group NV
$57K
4,091 sh0.03%+0.8% - ORGS
Orgenesis, Inc.
$21K
50,623 sh0.01%+0.0%
| Security | Shares | Value | Change | Weight | Period |
|---|---|---|---|---|---|
BHVN1 Biohaven Pharmactl Hldg Co | 2.35M | $35.01M | +1.0% | 16.33% | Q2 2026 |
MGTX MeiraGTX Holdings | 1.25M | $16.89M | +0.0% | 7.88% | Q2 2026 |
PHYS Sprott physical gold Trust | 387,055 | $11.68M | +0.0% | 5.45% | Q2 2026 |
ALDX Aldeyra Therapeutics Inc | 5.48M | $11.66M | +0.0% | 5.44% | Q2 2026 |
OCUL Ocular Therapeutix Inc. | 1.15M | $11.3M | +91.6% | 5.27% | Q2 2026 |
RGLD Royal Gold Inc. | 52,750 | $10.53M | +0.0% | 4.91% | Q2 2026 |
ENTX Entera Bio Ltd | 5.88M | $10.41M | +0.0% | 4.86% | Q2 2026 |
NUVB Nuvation Bio Inc | 1.60M | $9.08M | +6.7% | 4.24% | Q2 2026 |
AEM Agnico Eagle Mines Ltd | 52,750 | $8.18M | +0.0% | 3.82% | Q2 2026 |
SA SEABRIDGE GOLD INC | 317,003 | $8.16M | +0.0% | 3.81% | Q2 2026 |
KGC Kinross Gold Corp | 320,000 | $7.56M | +0.0% | 3.53% | Q2 2026 |
OR OR Royalties | 225,000 | $7.12M | +0.0% | 3.32% | Q2 2026 |
SSRM SSR Mining In | 245,000 | $6.93M | +0.0% | 3.23% | Q2 2026 |
FNV Franco Nev Corp | 32,000 | $6.67M | +0.0% | 3.11% | Q2 2026 |
BAH Booz Allen Hamilton HLDG COR | 13,000 | $5.69M | +0.0% | 2.66% | Q2 2026 |
CGAU Centerra Gold Inc | 359,000 | $5.69M | +0.0% | 2.66% | Q2 2026 |
ELTX Elicio Therapeutics Inc | 1.21M | $4.74M | +92.1% | 2.21% | Q2 2026 |
ABVX Abivax SA Spons | 35,000 | $4.66M | New | 2.18% | Q2 2026 |
PAAS Pan American Silver | 100,035 | $4.48M | +0.0% | 2.09% | Q2 2026 |
PSLV Sprott Physical silver Trust | 222,160 | $4.19M | +0.0% | 1.96% | Q2 2026 |
TFPM Triple Flag Precious Metals | 115,000 | $3.45M | +0.0% | 1.61% | Q2 2026 |
ABEO Abeona Therapeutics | 485,515 | $3M | +0.0% | 1.40% | Q2 2026 |
GROY Gold RTY Corp | 1.00M | $2.76M | +0.0% | 1.29% | Q2 2026 |
NEWP New Pac Metals Corp | 485,000 | $1.95M | +0.0% | 0.91% | Q2 2026 |
ITA iSHares US Aerospace & Defense | 7,650 | $1.85M | +0.0% | 0.87% | Q2 2026 |
PM Philip Morris Intl. Inc | 10,000 | $1.81M | +0.0% | 0.84% | Q2 2026 |
CDE Coeur Mining Inc | 96,132 | $1.57M | +0.0% | 0.73% | Q2 2026 |
AGI Alamos Gold Inc | 50,000 | $1.52M | +0.0% | 0.71% | Q2 2026 |
WPM Wheaton Precious Metals Corp | 12,500 | $1.4M | +0.0% | 0.66% | Q2 2026 |
NOC Northrop Grumman Corp | 2,165 | $1.1M | +0.0% | 0.51% | Q2 2026 |
ELE Elemental RTY Corp | 50,000 | $873K | +0.0% | 0.41% | Q2 2026 |
VMET Versamet Royalties Corp | 66,621 | $821K | +0.0% | 0.38% | Q2 2026 |
DC Dakota Gold Corp | 122,921 | $524K | +0.0% | 0.24% | Q2 2026 |
AMRZ Amrize LTD | 9,175 | $489K | +0.0% | 0.23% | Q2 2026 |
ALT Altimmune Inc | 160,000 | $486K | +0.0% | 0.23% | Q2 2026 |
PHAR Pharming Group NV | 4,091 | $57K | +0.8% | 0.03% | Q2 2026 |
ORGS Orgenesis, Inc. | 50,623 | $21K | +0.0% | 0.01% | Q2 2026 |
1-37 of 37 holdings
Sector Allocation
SEC Filings
| Form | Description | Filed |
|---|---|---|
Knoll Capital Management, LLC filed its most recent 13F holdings report, covering Q2 2026 (the quarter ended Jun 30, 2026), on Aug 14, 2026. Its largest reported positions by value are BHVN1, MGTX, PHYS, ALDX and OCUL. A 13F lists US-listed stock and option positions, not total assets under management.
About Knoll Capital Management, LLC
Knoll Capital Management, LLC is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 1325083). Signal8 holds 27 13F filings from it. Its SEC filings list Florida as its state of incorporation.
Its most recent 13F holdings report covers Q2 2026 (the quarter ended Jun 30, 2026) and was filed on Aug 14, 2026. That report lists 37 securities, not counting options, the same number as in Q1 2026.
Its five largest reported positions, in order, are Biohaven Pharmactl Hldg Co (BHVN1), MeiraGTX Holdings (MGTX), Sprott physical gold Trust (PHYS), Aldeyra Therapeutics Inc (ALDX) and Ocular Therapeutix Inc. (OCUL). The next five are Royal Gold Inc. (RGLD), Entera Bio Ltd (ENTX), Nuvation Bio Inc (NUVB), Agnico Eagle Mines Ltd (AEM) and SEABRIDGE GOLD INC (SA).
Recent 13F filings by Knoll Capital Management, LLC
- Q2 2026: 13F-HR/A filed Sep 9, 2026, listing 37 securities.
- Q2 2026: 13F-HR filed Aug 14, 2026, listing 37 securities.
- Q1 2026: 13F-HR filed May 15, 2026, listing 37 securities.
- Q4 2025: 13F-HR filed Feb 17, 2026, listing 33 securities.
- Q3 2025: 13F-HR filed Nov 14, 2025, listing 38 securities.
- Q2 2025: 13F-HR filed Aug 14, 2025, listing 38 securities.